Assessment of Resistance Mechanisms and Clinical Implications in Patients With<i>EGFR</i>T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib

Geoffrey R. Oxnard, Pasi A. Jänne, Suzanne E. Dahlberg et al.|JAMA Oncology|2018

Cited by 689